FDA Investigator Iram R Hassan, PhD
Iram R Hassan, PhD has inspections in 9 countries as of 12 Dec 2023. Iram R Hassan, PhD has collaborated with a combined 3646 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
130
Last Inspection Date:
12 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada,
France,
Brazil,
Norway,
Germany,
India,
Poland,
United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Alia Legaux,
Alice S Tsao,
Althea A Williams,
Amanda E Lewin, PhD,
Amatul H Marium,
Amber D Brodas,
Amy Kim,
Amy W Yan Mai,
Andrew B Paglia, DPM,
Andrew F Cohen,
Andrew J Garufi,
Andrew M Abramowitz,
Ann B Borromeo,
Ann M Stewart,
Arthur S Williams, Jr,
Ashley Defilippis,
Aziz A Mamur,
Barbara D Wright,
Bei Yu,
Benton M Ketron,
Bernardica T Sculac Stern,
Betty M Ng Lee,
Bijoy Panicker,
Brandy D Brown,
Brian M Brodman,
Byungja E Marciante,
Cara M Minelli,
Carmen Y Fisher,
Carrie E Jolly,
CDR Ileana Barreto Pettit,
Charanjeet Jassal,
Charisse K Green,
Christian Parra,
Christine M Rivera,
Christopher B May,
Christopher S Fields,
Claudette D Brooks,
Coleburn E Vielehr,
Courtney N Long,
Craig T Rybus,
Ct Viswanathan, PhD,
D Jenny Argiropoulos,
Dave M Deroche,
David R Delucia,
Dawn C Olenjack,
Demitria J Xiradakis,
Denise R Beuttenmuller,
Diane Cvan Leeuwen,
Dilijeta Bajrami,
Dongping Dai, PhD,
Douglas G Ng,
Dr. Abhijit Raha, PhD,
Dr. Robert C Horan, MD,
Edouard Viard,
Emilio Z Azukwu,
Eric J Reisenauer,
Erica B Raphael,
Evan Tong,
Evelyn Taha,
Felix Maldonado,
Frank Verni,
George C Amedro,
Gerald B Seaborn, Jr,
Gifford Whitehurst, Jr,
Gray,
Gregson A Joseph,
Gwyn G Dickinson,
Harry J Brewer,
Hasan A Irier, PhD,
Helen B Ricalde,
Iram Hassan,
Irina Gaberman,
Jacqueline S Warner,
James A Liubicich,
James I Giefer,
James L Dunnie, Jr,
James R Fleckenstein,
Jane Chen,
Janete F Guardia,
Jason Kwong,
Jay T Wong,
Jennifer L Custodio,
Joanne M Schlossin,
Jogy George,
John B Crowe,
John P Shelton,
Jonathan D Green,
Jose O Hernandez,
Joseph Duca,
Joseph Maselli,
Joy P Matthias,
Juliana Falla,
Karen L Kosar,
Karen M Cooper,
Kellie Leveille,
Kerry D Noto,
Kerun Hardeo,
Kevin A Gonzalez,
Kim Lthomas Cruse,
Kim M Downing,
Kimberley A Ricketts,
Kimberly A Benson,
Kimberly Y Smithson,
Kwong P Lee,
L Gnnmassimia Massimilla, PharmD,
Lata C Mathew, PhD,
Lawrence W Farina,
LCDR Chad N Thompson,
Leena Thomas,
Lisa Mathew,
Lorie S Hannappel,
LT Richard A Lyght,
LTJG Matthew R Palo,
M Patriciaurphy Murphy,
Matthew A Spalazo,
Matthew A Spataro,
Matthew C Watson,
Melanie M Walker,
Melissa B Libby,
Melkamu Getie Kebtie, PhD,
Meredith P Soehl, Investigator,
Michael A Charles,
Michael F Skelly, PhD,
Michael Levin,
Michael P Sheehan,
Michael R Dominick,
Michael Serrano,
Michele C Murray Schrade,
Michelle M Noe Varga,
Milan S Kunajukr,
Milan S Mcgorty,
Mindy M Chou,
Miral B Patel,
Mohsen Rajabi Abhari, FDA,
Neil J Bonzagni, PhD MPH,
Ni A Khin, MD,
Nicholas J Morici,
Nicole Vaught,
Nina Yang,
Noreen Muniz,
Omadevi Somai, Investigator,
Osama A Khatib,
Patrick A Bowen,
Patrick C Klotzbuecher,
Paul Mouris,
Pearl L Gonzalez,
Perry T Nichols,
Peter Abel,
Peter M Trunk,
Peter R Caparelli,
Peter S Diak,
Preston M Lee,
Rachael A Moliver,
Randolph Campos Santiago,
Raymond M Lam,
Renee S Blosser,
Rita F Monfort,
Robert C Steyert,
Robert E Moncayo,
Rochelle K Kimmel,
Roger F Zabinski,
Ronald Ifraimov,
Rose Xu,
Russ E Davis,
S Lori Brown, PhD MPH,
S Thomas,
Samantha N Mccormick,
Sarah A Meehan,
Satheesh Thomas,
Scott B Laufenberg,
Shari L Kahn,
Shreya Shah,
Simone E Pitts,
Sonia E Ortiz,
Sony Mathews,
Sripal R Mada, PhD,
State Agency,
Stephanie T Durso,
Steven J Libal,
Stuart W Russell,
Sunita Vij,
Susan P Bruederle,
Susanne M Richardson, MSc RAC ELS,
Syeda N Mahazabin,
Taina Pierre Pierre,
Tara K Carmody,
Tara K Normandin,
Tawny L Colling,
Theressa B Smith,
Thomas E Friel,
Thomas J Mooney,
Thomas P Hansen,
Traci C Kelm,
Tracy M Portelli,
Uduak M Inokon,
Valerie A Potopsingh,
Valerie J Grecek Trinh,
Vanessa M Williams,
Vivin George,
Wayne J Meyer,
Xiaoping Guan,
Xikui Chen (nmi), PhD,
Yuyan Liang,
Yvesna C Blaise,
Zameer Farouk
Iram R Hassan, PhD's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more